India, Feb. 16 -- A pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services has come into the spotlight after its shares hit 10 percent upper circuit, attracting attention from investors and market watchers.

With a market capitalization of Rs. 7,539.96 crore, the shares of Akums Drugs and Pharmaceuticals Limited were trading at Rs. 479.25, up by 6.35 percent from its previous day's closing price of Rs. 450.65 per equity share. The stock has touched an intraday high of Rs. 495.70, hitting an upper circuit of 10 percent from previous day's closing price.

Q3FY26 Results In Q3FY26, the company reported a revenue of Rs. 1,160 crore, up 14.9 percent YoY f...